0.0460
-0.0040
(-8.00%)
At close: 2:05:07 PM GMT+10
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Cash Flows from Used in Operating Activities Direct
-404.7570
-404.7570
-433.6080
-392.9110
-366.1520
Investing Cash Flow
-197.8030
-197.8030
--
-2,205.5710
-15.1620
Financing Cash Flow
887.8160
887.8160
--
2,400
--
End Cash Position
2,022.1550
2,022.1550
1,736.8850
2,170.4930
2,368.9750
Issuance of Capital Stock
887.8160
887.8160
--
2,500
--
Issuance of Debt
4,000
--
--
--
--
Repurchase of Capital Stock
--
--
--
-100
--
Free Cash Flow
-404.7570
-404.7570
-433.6080
-392.9110
-366.1520
6/30/2021 - 8/27/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IXC.AX Invex Therapeutics Ltd
0.0700
0.00%
NSB.AX NeuroScientific Biopharmaceuticals Limited
0.0350
0.00%
VBS.AX Vectus Biosystems Limited
0.0800
0.00%
TRP.AX Tissue Repair Ltd
0.2400
0.00%
1AI.AX Algorae Pharmaceuticals Limited
0.0060
+20.00%
ANR.AX Anatara Lifesciences Ltd
0.0060
0.00%
RNV.AX RENERVE FPO [RNV]
0.1100
+4.76%
BGT.AX Bio-Gene Technology Limited
0.0310
0.00%
ATX.AX Amplia Therapeutics Limited
0.0520
-1.89%
CMB.AX Cambium Bio Limited
0.3000
+7.14%